Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adults

The study will evaluate the safety, tolerability, and immunogenicity of a single injection of up to 4 dose levels of IN006 in younger adults and 3 dose levels of IN006 in older adults; of a revaccination of IN006 given approximately 12 months after the initial vaccination in older adults.

Participants needed: 200
Trial details
Phase: Phase 1Age: 18-79Biological sex: AllType: InterventionalSponsor: Shenzhen Shenxin Biotechnology Co., LtdUpdated: Apr 13, 2026
Eligibility criteria

Healthy male or female participants aged ≥18 to 59 years of age (Part 1) or ≥ 60... [+5]

Pregnant or lactating at Screening or prior to vaccination or planning to become... [+20]

Read more
Status: Not yet recruiting

A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

The study will evaluate the safety, tolerability, and immunogenicity (your immune system's reaction) of 3 dose levels of the study vaccine called Herpes Zoster IN001 mRNA Vaccine (IN001) in healthy participants who are between 50 and 79 years of age.

Participants needed: 480
Trial details
Phase: Phase 2Age: 50-79Biological sex: AllType: InterventionalSponsor: Shenzhen Shenxin Biotechnology Co., LtdUpdated: Oct 7, 2025
Eligibility criteria

Male or female adults, of any race or ethnicity, between 50 and 79 years of age,... [+8]

Participants with a known history of HZ. [+27]

Read more